(CANCERRESEARCH57, 4149-4151, September 15, 19971 Announcements (Requestsfor announcements must be received at least three months before publication.)

1998 ANNUAL MEETING thy work. The committee will make its selection solely on the basis of the awardee's scientific accomplishments without regard to race, gender, nation The AACR's Annual Meeting is one of the largest and most important ality, or religious or political views. The candidate will give an award lecture annual gatherings of scientists engaged in cancer research worldwide. The next during the AACR Annual Meeting in New Orleans, USA (March 28—April1, Annual Meeting will take place in New Orleans, LA, March 28—April 1, 1998. 1998) and will receive the award in a ceremony at the Foundation's headquar The Chairpersonofthe AnnualMeetingis FrankJ. RauscherIll of the Wistar ters in Trento, Italy, right after the annual meeting. The award consists of an Institute. The Program Committee will invite outstanding scientists in the field honorarium of US $100,000 and a commemorative plaque. to organize plenary sessions, symposia, controversy sessions, and meet-the The Foundation and the AACR are now soliciting nominations for the 1998 expert sunrise sessions. They also look forward to receiving for consideration Award. Nominations can be made by any scientist who is now or has been for presentation the proffered papers submitted by members of the cancer affiliated with an institution engaged in cancer research. Institutions or orga research community. All abstracts must be sponsored by an AACR member in nizations are not eligible for this award, and candidates may not nominate good standing. The deadline for receipt ofabstmacts in the AACR office will themselves. be October 28, 1997. There is no official application form for this award. The nomination pack age should consist of the following: FUTURE ANNUAL MEETINGS OF THE AMERICAN I the candidate's curriculum vitae ASSOCIATION FOR CANCER RESEARCH . an indication of the most important references in the candidate's curriculum vitae and list of publications 1999 April 10—14,Philadelphia, PA S a letter of recommendation in English (500 words, maximum) describing the 2000 April 1-5, San Francisco, CA candidate's major scientific achievements and explaining the impact of these achievements on progress in cancer research Nominators are asked to maintain the confidentiality of the nomination CALL FOR NOMINATIONS FOR 1998 AACR-PEZCOLLER process and to refrain from informing the candidate about the nomination. INTERNATIONAL AWARD FOR CANCER RESEARCH The deadline for receipt of nominations by the AACR is September 30, 1997, for consideration for the 1998 Award. Questions about the nomination AACR-Pezcoller International Award Committee process should be directed to the AACR Office via FAX at (215) 440-93 13 or Carlo M. Croce, M.D., Chairperson, Kimmel Cancer Center, Philadelphia, E-mail at [email protected]. Nominators should submit the original plus 12 copies USA of their nominations to: Laurent Degos, M.D., Ph.D., University of Paris, Paris, France Carlo M. Croce, M.D., Chairperson, Selection Committee Giuseppe Della Ports, M.D., European Institute of , Milan, Italy AACR-Pezcoller International Award for Cancer Research Gertrude B. Elion, D.Sc., Glaxo Wellcome, Inc., Research Triangle Park, USA do American Association for Cancer Research, Inc. Judah Folkman, M.D., Harvard Medical School, Boston, USA Public Ledger Building, Suite 826 Carl-Henrik Heldin, Ph.D., Ludwig Institute for Cancer Research, Uppsala, 150 South Independence Mall West Sweden Philadelphia, PA 19106-3483 Bruce A. J. Ponder, Ph.D., CRC Human Cancer Research Group, USA Cambridge, United Kingdom Peter K. Vogt, Ph.D., Scripps Research Institute, La Jolla, USA Ex officio CALL FOR NOMINATIONS FOR HONORARY MEMBERSHIP David M. Livingston, M.D., Dana-Farber Cancer Institute, Boston, USA Enrico Mihich, M.D., Roswell Park Cancer Institute, Buffalo, USA As stated in the Association's By-Laws, “Honorarymembershipshall be open to distinguished scientists who have made extraordinary contributions to The AACR-Pezcoller International Award for Cancer Research is given the advancement of cancer research either through outstanding personal sd biennially to a scientist who has made a major scientific discovery in the field entific activity or through exceptional administrative leadership in cancer of cancer. The Pezcoller Foundation was established in 1982 by Professor research.―Honorarymembership in the AACR is reserved for a select, small Alessio Pezcoller, a dedicated Italian surgeon who has made important con group of investigators; there are currently only 20 honorary members in our tributions to medicine during his career and who, through his foresight, vision, total membership of more than 13,000. (See Page 1 of the current AACR and generous gift in support of the formation of the Foundation, stimulated Directory ofMembers for a list of Honorary members.) others to make significant advances in cancer research. Over the past decade The Special Memberships Committee will review all candidates for honor the Pezcoller Foundation has given a major award for outstanding contribu ary membership and will determine whether to recommend any candidates for tions to cancer and cancer-related biomedical science. election by the Board of Directors. Members wishing to make nominations for The AmericanAssociation for CancerResearch(AACR) was founded in honorary membership should send a letter describing the outstanding achieve 1907 by eleven physicians and scientists dedicated to the conquest of cancer ments of the candidate. Since this person will be, by definition, a prominent and now has over 13,000 members in more than 60 countries who are experts researcher, the nominator does not need to supply a curriculum vitae or in basic, clinical, and translational cancer research. The AACR fulfills its reprints. Nominations should be submitted by October 20, 1997, and may be mission, the communication of important scientific results, in a variety of sent to the Association Office. forums including publications, meetings, and training and educational pro grams. Because of their joint commitment to scientific excellence in cancer research, the Foundation and the AACR have now agreed to collaborate on the AACR MINORITY SCHOLAR AWARDS IN CANCER presentation of this award. This will strengthen their already well-established RESEARCH SUPPORTED BY THE NATIONAL CANCER relationship and facilitate international collaborations and interactions. INSTITUTE (CMBP) The awardee will be selected by an international committee of AACR members appointed by the AACR President with the agreement of the Council Funds are being provided through the Comprehensive Minority Biomedical of the Pezcoller Foundation. Although normally the Award will be presented Program of the National Cancer Institute for the travel of a limited number of to a single investigator, in exceptional cases two individuals may be selected minority students to the 1998 AACR Annual Meeting. Eligible scientists are to share the award when their investigations have resulted in related prizewor full-time predoctoral students, postdoctoral fellows, and physicians-in-training 4149

Downloaded from cancerres.aacrjournals.org on September 25, 2021. © 1997 American Association for Cancer Research. ANNOUNCEMENTS in the early stages of their careers who are either engaged in cancer research AACR SPECIAL CONFERENCES IN CANCER RESEARCH or who have training that could lead to contributions in this field. This travel award program applies only to minority groups that have A number of meetings are now being organized in the AACR's series of been defined by the National Cancer Institute as being traditionally under smaller scientific meetings. Following are the topics, dates, locations, and represented in cancer research; these groups are Native Americans, African program committees for these meetings. When full details of each meeting Americans, Hispanic Americans, Alaskan Americans, and Native Pacific Is are available, AACR members will be the first to receive complete bro chures and application forms for participation in these important confer landers. Only citizens of the United States and Canada or scientists who are ences. Nonmembers may receive this information by sending their names permanent residents in those countries may receive one of these awards. and addresses to Meetings Mailing List, American Association for Cancer Although preference will be shown to authors of abstracts that have been Research, Public Ledger Building, 150 South Independence Mall West, accepted for presentation at the annual meeting, this is not a requirement for Suite 826, Philadelphia, PA 19106-3483. Up-to-date program information the award. Preference will also be given to new applicants. Awardees will be is also available via the Internet at the AACR's website (http://www. selected on the basis of their qualifications, references from mentors, and an aacr.org/confrnc.html). estimation of the potential professional benefit to the Awardees. An advisory committee consisting of members of the AACR will review submitted appli cations and letters of reference. The award will consist of partial support of registration, travel, and subsistence expenses incurred in connection with TUMOR SUPPRESSOR GENES attendance at the annual meeting. Co-sponsored by the National Cancer Institute of Canada Applicants will be chosen from minority institutions as well as the larger September 26—30,1997 bodies of universities, colleges, and research institutes. Travel grants are Victoria Conference Centre, Victoria, BC, Canada awarded to the applicant's institution to permit a minimum of 4 days of attendance at the annual meeting. If accepted, applicants will be expected to participate in all planned activities for the Awardees. They are required to Chairpersons submit a brief report commenting on the Minority Scholar Program and the Stephen H. Friend, Seattle, WA scientific sessions they attended at the annual meeting. Philip Branton, Montreal, Quebec, Canada Further information and application forms are available from the AACR Office. Letters of reference should accompany the application. The deadline for receipt of applications is December 1, 1997. Grants from this program are TRANSCRIPTIONAL CONTROL OF PROLIFERATION, also available for attendance at AACR Special Conferences taking place in DIFFERENTIATION, AND DEVELOPMENT North America. The brochure for each meeting contains all the necessary October 17—21, 1997 information. The Sagamore Resort, Bolton Landing (Lake George), NY

Chairpersons GERTRUDE B. ELION CANCER RESEARCH AWARD Robert Eisenman, Seattle, WA Elaine V. Fuchs, Chicago, IL Application forms for the AACR's 1998 Gertrude B. Elion Cancer Research Award, supported by an educational grant from Glaxo Wellcome Oncology, will soon be available. This one-year, $30,000 grant to a nontenured Assistant Professor supports meritorious basic, clinical, or translational research in DNA METHYLATION, IMPRINTING, AND THE EPIGENETICS OF CANCER cancer causation, prevention, or treatment. Tenured faculty in academia, fed December 12—16,1997 eral government employees, and employees of private industry are not eligible El Conquistador Resort and Country Club, Las Croabas, PR for this award. Information and application forms will be mailed to AACR members and to those who requested application materials in the past as soon as they are available. Nonmembers who have not previously requested infor Chairpersons mation or who have changed addresses should request information and appli Peter A. Jones, Los Angeles, CA cation forms from the AACR Office. Stephen B. Baylin, Baltimore, MD Timothy H. Bestor, New York, NY

AACR RESEARCH FELLOWSHIPS MOLECULAR MECHANISMS OF APOPTOSIS REGULATION In 1998, the AACR will offer an enhanced program of sponsored fellow January 9—13,1998 ships for clinical and postdoctoral fellows. The basic, clinical, translational, Renaissance Esmeralda Resort, Palm Springs, CA and prevention fellowships will offer salary support at the level of $30,000 per year, with some fellowships extending for a term of two years. Eligibility has Chairpersons been expanded to include all citizens and permanent residents of any country John C. Reed, La Jolla, CA in the Americas, who have completed the M.D., Ph.D., or other doctoral Vishva M. Dixit, S. San Francisco, CA degree. Candidates must currently be a postdoctoral or clinical research fellow and must have been a fellow for at least two years but not more than five years prior to the year of the award. Medical residents, employees of industry, fellows with sponsorship for a similar program for the award year, and ANGIOGENESIS AND CANCER permanent employees of the federal government are not eligible. All Active, January 24—28, 1998 Corresponding, and Associate AACR members in the Americas will receive Hyatt Orlando, Orlando, FL information and application forms by mail in the early Fall. Nonmembers may request information and application forms from the AACR Office. The dead Chairpersons line for applications will be early 1998, with the commencement of the award Judah Folkman, Boston, MA yearonJuly 1, 1998. Michael Klagsbrun, Boston, MA 4150

Downloaded from cancerres.aacrjournals.org on September 25, 2021. © 1997 American Association for Cancer Research. ANNOUNCEMENTS

INNOVATIVE MOLECULAR APPROACHES TO THE Molecular and Cellular Biology of Gene Therapy, January 19—25,1998, PREVENTION, DIAGNOSIS, AND THERAPY OF CANCER Keystone, CO. Abstract deadline: October 20, 1997. Early registration dead Joint Meeting with the Japanese Cancer Association line: November 19, 1997. Contact: Keystone Symposia, Drawer 1630, February16—21,1998 Silverthorne, CO 80498. Phone: (800) 253-0685 or (970) 262-1230; Fax: (970) Maui Marriott Hotel, Maui, HI 262-1525; E-mail: [email protected].

Chairpersons Synthetic Non-Viral Gene Delivery Systems, January 19—25,1998,Keystone, Edward Bresnick, Worcester, MA CO. Abstractdeadline:October20, 1997. Earlyregistrationdeadline:Novem Kaoru Abe, Tokyo, Japan ber 19, 1997. Contact: Keystone Symposia, Drawer 1630, Silverthorne, CO 80498. Phone: (800) 253-0685 or (970) 262-1230; Fax: (970) 262-1525; CALENDAR OF EVENTS E-mail: [email protected].

First Annual Michael S. Voynick Neuro-Oncology Symposium, September 20, T LymphocyteActivation,Differentiation,andDeath,January26—February1, 1997, New Haven, 0'. Contact: Office of Postgraduate and Continuing Mcd 1998, Keystone, CO. Abstract deadline: October 27, 1997. Early registration ical Education, Yale University School of Medicine, 333 Cedar St., P.O. Box deadline: November 26, 1997. Contact: Keystone Symposia, Drawer 1630, 208052, New Haven, CT 06520-8052. Phone: (203) 785-4578; Fax: (203) Silverthorne, CO 80498. Phone: (800) 253-0685 or (970) 262-1230; Fax: (970) 785-3083. 262-1525; E-mail: [email protected]. Sixth Regional Symposium on the Design and Methods of Clinical Trials, October 16—17,1997, San Francisco, CA. Contact: Office of Continuing Signal Transduction by JAKs and STATs, February 3—8, 1998, Tamarron, CO. Medical Education, Registration Office, Room MCB-630, University of Abstract deadline: November 3, 1997.Early registration deadline: December 3, California, San Francisco, CA 94143-0742. Phone: (415) 476-5808. 1997. Contact: Keystone Symposia, Drawer 1630, Silverthorne, CO 80498. Phone: (800) 253-0685 or (970) 262-1230; Fax: (970) 262-1525; E-mail: Seventeenth International Symposium on the Separation of Proteins, Peptides, [email protected]. and Polynucleotides, October 26—29,1997,Washington, DC. Contact: Janet Cunningham, Barr Enterprises, P.O. Box 279, Walkersville, MD 21793. Cardiovascular Health: Coming Together for the 21st Century, February 19— Phone:(301) 898-3772; Fax: (301) 898-5596; E-mail:[email protected]. 21, 1998, Hyatt Regency Embarcadero, San Francisco, CA. Contact: CORE Fourth Annual Conference on Apoptosis: Therapeutic Strategies for Regulat Program, Attn. Greg Oliva, Department of Health Services, Mail Station #725, ing Cell Death, October 27—28,1997,Westin Hotel Horton Plaza, San Diego, P.O. Box 942732, Sacramento, CA 94234-7320. E-mail: goliva@hwl. CA. Contact: IBC USA Conferences, 225 Turnpike Road, Southborough, MA cahwnet.gov. 01772-1749.Phone:(508)481-6400;Fax: (508)481-7911;E-mail:inq@ ibcusa.com. Advances in Oncology Nursing, February 20—21,1998,Houston, TX. Contact: University of Texas M. D. Anderson Cancer Center, Office of Conference Dana-FarberCancer Institute's Fiftieth AnniversaryScientific Symposium, Services, Box 131, 1515 Holcombe Boulevard, Houston, TX 77030-4095. October 30-November 1, 1997, Boston, MA. Contact: Professional Meeting Phone: (713) 792-2222; Fax: (713) 794-1724; E-mail: meetings@mdacc. Planners, 5 Central Square, Suite 201, Stoneham, MA 02180. Phone: (617) tmc.edu. 279-9887 or (800) 378-6857; Fax: (617) 279-9875; E-mail: [email protected]. Breast and Prostate Cancer, February 21-26, 1998, Copper Mountain, CO. Gene Therapy Strategies for Hematopoietic Cells, January 10—15,1998,Lake Abstract deadline: November 21, 1997. Early registration deadline: December Tahoe, NV. Abstract deadline: October 10, 1997. Early registration deadline: 22, 1997. Contact: Keystone Symposia, Drawer 1630, Silverthorne, CO 80498. November 10, 1997.Contact: Keystone Symposia, Drawer 1630,Silverthome, Phone: (800) 253-0685 or (970) 262-1230; Fax: (970) 262-1525; E-mail: CO 80498. Phone:(800) 253-0685 or (970) 262-1230; Fax: (970) 262-1525; [email protected]. E-mail: [email protected]. Motility and Metastasis, February 21—26,1998,Copper Mountain, CO. Ab Genomics and Drug Discovery, January 10—15,1998,Santa Fe, NM. Abstract stract deadline: November 21, 1997. Early registration deadline: December 22, deadline: October 10, 1997. Early registration deadline: November 10, 1997. 1997. Contact: Keystone Symposia, Drawer 1630, Silverthorne, CO 80498. Contact: Keystone Symposia, Drawer 1630, Silverthome, CO 80498. Phone: Phone: (800) 253-0685 or (970) 262-1230; Fax: (970) 262-1525; E-mail: (800) 253-0685 or (970) 262-1230; Fax: (970) 262-1525; E-mail: keystone® [email protected]. symposia.com.

International Symposium on Metastases in Head and Neck Cancer, January Transcriptional Mechanisms, February 21—26, 1998, Taos, NM. Abstract dead 15—18,1998,Kid, Germany. Contact: Dr. J. A. Werner or Dr. B. M. Lippert, line: November 21, 1997. Early registration deadline: December 22, 1997. Dept. of Otorhinolaryngology, Head and Neck Surgery, University of Kid, Contact: Keystone Symposia, Drawer 1630, Silverthome, CO 80498. Phone: Arnold-Heller-Str. 14, D-24l05 Kid, Germany. Phone: 49-431-597-2321; (800) 253-0685 or (970) 262-1230; Fax: (970) 262-1525; E-mail: Fax: 49-431-597-2272; E-mail: [email protected]. [email protected].

4151

Downloaded from cancerres.aacrjournals.org on September 25, 2021. © 1997 American Association for Cancer Research. Announcements

Cancer Res 1997;57:4149-4151.

Updated version Access the most recent version of this article at: http://cancerres.aacrjournals.org/content/57/18/4149.citation

E-mail alerts Sign up to receive free email-alerts related to this article or journal.

Reprints and To order reprints of this article or to subscribe to the journal, contact the AACR Publications Subscriptions Department at [email protected].

Permissions To request permission to re-use all or part of this article, use this link http://cancerres.aacrjournals.org/content/57/18/4149.citation. Click on "Request Permissions" which will take you to the Copyright Clearance Center's (CCC) Rightslink site.

Downloaded from cancerres.aacrjournals.org on September 25, 2021. © 1997 American Association for Cancer Research.